Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CHBOF's EV-to-EBITDA is ranked better than 74.77% of 218
companies
in the Forest Products industry
Industry Median: 8.92
vs CHBOF: 5.90
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
China Health Technology Group Holding Co (OTCPK:CHBOF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Health Technology Group Holding Co's PE Ratio (TTM) for today is calculated as:
China Health Technology Group Holding Co's share price for today is $0.03296.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Technology Group Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co EV-to-EBITDA Chart
China Health Technology Group Holding Co Annual Data
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co EV-to-EBITDA vs Forest Products Industry
China Health Technology Group Holding Co's current Enterprise Value is $22.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Technology Group Holding Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $3.81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co (CHBOF) has a EV-to-EBITDA of 5.90 as of Aug. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on China Health Technology Group Holding Co. This is 794% above median its historical median of 0.66. According to the industry distribution chart, China Health Technology Group Holding Co ranks #55 out of 218 companies in the Forest Products industry, placing it in the top 25.2%.
Is China Health Technology Group Holding Co's EV-to-EBITDA too high?
China Health Technology Group Holding Co's current EV-to-EBITDA of 5.90 is 794% above median its 10-year median of 0.66. The Forest Products industry median EV-to-EBITDA is 8.92. China Health Technology Group Holding Co's value of 5.90 is 33.9% below this industry median. Based on the distribution chart, China Health Technology Group Holding Co ranks #55 out of 218 companies in the Forest Products industry, which is above the industry midpoint. Overall, China Health Technology Group Holding Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's EV-to-EBITDA compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #55 out of 218 companies for EV-to-EBITDA. This puts China Health Technology Group Holding Co in the upper half of its industry. The industry median EV-to-EBITDA is 8.92. China Health Technology Group Holding Co's value of 5.90 is 33.9% below this benchmark. While the company's 10-year median is 0.66 vs. the industry median of 8.92, China Health Technology Group Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Forest Products company?
The median EV-to-EBITDA among Forest Products companies is 8.92, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current EV-to-EBITDA of 5.90 is 33.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on China Health Technology Group Holding Co. For the Forest Products industry, the median EV-to-EBITDA is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current EV-to-EBITDA is 5.90, which is 794% above median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current EV-to-EBITDA of 5.90. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current EV-to-EBITDA is 5.90, which is 794% above median its 10-year median of 0.66 and 33.9% below the Forest Products industry median of 8.92. China Health Technology Group Holding Co's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current EV-to-EBITDA is 5.90 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.
Key valuation signals for CHBOF:
EV-to-EBITDA: 5.90 (794% above median its 10-year median of 0.66)
GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
Industry Position: 33.9% below the Forest Products median (#55 of 218)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
28GF Score
Get the complete analysis for CHBOF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
